nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Gastrointestinal disorder—Vemurafenib—melanoma	0.00368	0.00368	CcSEcCtD
Meropenem—Haemoglobin—Bleomycin—melanoma	0.00365	0.00365	CcSEcCtD
Meropenem—Constipation—Vemurafenib—melanoma	0.00364	0.00364	CcSEcCtD
Meropenem—Haemorrhage—Bleomycin—melanoma	0.00363	0.00363	CcSEcCtD
Meropenem—Pulmonary oedema—Docetaxel—melanoma	0.00361	0.00361	CcSEcCtD
Meropenem—Dysuria—Temozolomide—melanoma	0.00358	0.00358	CcSEcCtD
Meropenem—Neutropenia—Temozolomide—melanoma	0.00358	0.00358	CcSEcCtD
Meropenem—Pneumonia—Carmustine—melanoma	0.00355	0.00355	CcSEcCtD
Meropenem—Agranulocytosis—Dactinomycin—melanoma	0.00352	0.00352	CcSEcCtD
Meropenem—Sepsis—Docetaxel—melanoma	0.00352	0.00352	CcSEcCtD
Meropenem—Renal failure—Carmustine—melanoma	0.00347	0.00347	CcSEcCtD
Meropenem—Neuropathy peripheral—Carmustine—melanoma	0.00346	0.00346	CcSEcCtD
Meropenem—Pneumonia—Temozolomide—melanoma	0.00343	0.00343	CcSEcCtD
Meropenem—Phlebitis—Docetaxel—melanoma	0.00342	0.00342	CcSEcCtD
Meropenem—Infestation NOS—Temozolomide—melanoma	0.00341	0.00341	CcSEcCtD
Meropenem—Infestation—Temozolomide—melanoma	0.00341	0.00341	CcSEcCtD
Meropenem—Thrombophlebitis—Docetaxel—melanoma	0.0034	0.0034	CcSEcCtD
Meropenem—Hepatitis—Dactinomycin—melanoma	0.00339	0.00339	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00339	0.00339	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00339	0.00339	CcSEcCtD
Meropenem—Body temperature increased—Vemurafenib—melanoma	0.00337	0.00337	CcSEcCtD
Meropenem—Pharyngitis—Dactinomycin—melanoma	0.00336	0.00336	CcSEcCtD
Meropenem—Neuropathy peripheral—Temozolomide—melanoma	0.00335	0.00335	CcSEcCtD
Meropenem—Hepatic failure—Docetaxel—melanoma	0.00328	0.00328	CcSEcCtD
Meropenem—Chills—Bleomycin—melanoma	0.00326	0.00326	CcSEcCtD
Meropenem—Hepatobiliary disease—Temozolomide—melanoma	0.00323	0.00323	CcSEcCtD
Meropenem—Erythema multiforme—Dactinomycin—melanoma	0.0032	0.0032	CcSEcCtD
Meropenem—Haemoglobin—Carmustine—melanoma	0.00319	0.00319	CcSEcCtD
Meropenem—Haemorrhage—Carmustine—melanoma	0.00317	0.00317	CcSEcCtD
Meropenem—Erythema—Bleomycin—melanoma	0.00316	0.00316	CcSEcCtD
Meropenem—Hallucination—Carmustine—melanoma	0.00316	0.00316	CcSEcCtD
Meropenem—Hypersensitivity—Vemurafenib—melanoma	0.00314	0.00314	CcSEcCtD
Meropenem—Oedema peripheral—Carmustine—melanoma	0.00312	0.00312	CcSEcCtD
Meropenem—Haemoglobin—Temozolomide—melanoma	0.00308	0.00308	CcSEcCtD
Meropenem—Haemorrhage—Temozolomide—melanoma	0.00307	0.00307	CcSEcCtD
Meropenem—Hepatitis—Temozolomide—melanoma	0.00307	0.00307	CcSEcCtD
Meropenem—Asthenia—Vemurafenib—melanoma	0.00306	0.00306	CcSEcCtD
Meropenem—Hallucination—Temozolomide—melanoma	0.00305	0.00305	CcSEcCtD
Meropenem—Pharyngitis—Temozolomide—melanoma	0.00304	0.00304	CcSEcCtD
Meropenem—Chills—Dactinomycin—melanoma	0.00304	0.00304	CcSEcCtD
Meropenem—Oedema peripheral—Temozolomide—melanoma	0.00302	0.00302	CcSEcCtD
Meropenem—Cardiac failure—Docetaxel—melanoma	0.00302	0.00302	CcSEcCtD
Meropenem—Pruritus—Vemurafenib—melanoma	0.00301	0.00301	CcSEcCtD
Meropenem—Erythema—Dactinomycin—melanoma	0.00295	0.00295	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00295	0.00295	CcSEcCtD
Meropenem—Anaemia—Bleomycin—melanoma	0.00292	0.00292	CcSEcCtD
Meropenem—Diarrhoea—Vemurafenib—melanoma	0.00292	0.00292	CcSEcCtD
Meropenem—Erythema multiforme—Temozolomide—melanoma	0.0029	0.0029	CcSEcCtD
Meropenem—Malaise—Bleomycin—melanoma	0.00285	0.00285	CcSEcCtD
Meropenem—Leukopenia—Bleomycin—melanoma	0.00283	0.00283	CcSEcCtD
Meropenem—Dizziness—Vemurafenib—melanoma	0.00282	0.00282	CcSEcCtD
Meropenem—Immune system disorder—Temozolomide—melanoma	0.00277	0.00277	CcSEcCtD
Meropenem—Erythema—Carmustine—melanoma	0.00276	0.00276	CcSEcCtD
Meropenem—Cough—Bleomycin—melanoma	0.00276	0.00276	CcSEcCtD
Meropenem—Chills—Temozolomide—melanoma	0.00275	0.00275	CcSEcCtD
Meropenem—Anaemia—Dactinomycin—melanoma	0.00273	0.00273	CcSEcCtD
Meropenem—Vomiting—Vemurafenib—melanoma	0.00271	0.00271	CcSEcCtD
Meropenem—Chest pain—Bleomycin—melanoma	0.00269	0.00269	CcSEcCtD
Meropenem—Rash—Vemurafenib—melanoma	0.00269	0.00269	CcSEcCtD
Meropenem—Dermatitis—Vemurafenib—melanoma	0.00268	0.00268	CcSEcCtD
Meropenem—Back pain—Carmustine—melanoma	0.00267	0.00267	CcSEcCtD
Meropenem—Headache—Vemurafenib—melanoma	0.00267	0.00267	CcSEcCtD
Meropenem—Erythema—Temozolomide—melanoma	0.00267	0.00267	CcSEcCtD
Meropenem—Malaise—Dactinomycin—melanoma	0.00266	0.00266	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00265	0.00265	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00265	0.00265	CcSEcCtD
Meropenem—Leukopenia—Dactinomycin—melanoma	0.00264	0.00264	CcSEcCtD
Meropenem—Dysgeusia—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Meropenem—Confusional state—Bleomycin—melanoma	0.0026	0.0026	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Docetaxel—melanoma	0.0026	0.0026	CcSEcCtD
Meropenem—Anaphylactic shock—Bleomycin—melanoma	0.00258	0.00258	CcSEcCtD
Meropenem—Oedema—Bleomycin—melanoma	0.00258	0.00258	CcSEcCtD
Meropenem—Back pain—Temozolomide—melanoma	0.00258	0.00258	CcSEcCtD
Meropenem—Infection—Bleomycin—melanoma	0.00256	0.00256	CcSEcCtD
Meropenem—Anaemia—Carmustine—melanoma	0.00255	0.00255	CcSEcCtD
Meropenem—Agitation—Carmustine—melanoma	0.00254	0.00254	CcSEcCtD
Meropenem—Nausea—Vemurafenib—melanoma	0.00253	0.00253	CcSEcCtD
Meropenem—Thrombocytopenia—Bleomycin—melanoma	0.00253	0.00253	CcSEcCtD
Meropenem—Leukopenia—Carmustine—melanoma	0.00247	0.00247	CcSEcCtD
Meropenem—Anaemia—Temozolomide—melanoma	0.00247	0.00247	CcSEcCtD
Meropenem—Anorexia—Bleomycin—melanoma	0.00246	0.00246	CcSEcCtD
Meropenem—Agitation—Temozolomide—melanoma	0.00245	0.00245	CcSEcCtD
Meropenem—Angioedema—Temozolomide—melanoma	0.00244	0.00244	CcSEcCtD
Meropenem—Hypotension—Bleomycin—melanoma	0.00241	0.00241	CcSEcCtD
Meropenem—Oedema—Dactinomycin—melanoma	0.00241	0.00241	CcSEcCtD
Meropenem—Malaise—Temozolomide—melanoma	0.00241	0.00241	CcSEcCtD
Meropenem—Infection—Dactinomycin—melanoma	0.00239	0.00239	CcSEcCtD
Meropenem—Leukopenia—Temozolomide—melanoma	0.00239	0.00239	CcSEcCtD
Meropenem—Hypertension—Carmustine—melanoma	0.00238	0.00238	CcSEcCtD
Meropenem—Neutropenia—Docetaxel—melanoma	0.00238	0.00238	CcSEcCtD
Meropenem—Thrombocytopenia—Dactinomycin—melanoma	0.00236	0.00236	CcSEcCtD
Meropenem—Chest pain—Carmustine—melanoma	0.00235	0.00235	CcSEcCtD
Meropenem—Anxiety—Carmustine—melanoma	0.00234	0.00234	CcSEcCtD
Meropenem—Cough—Temozolomide—melanoma	0.00233	0.00233	CcSEcCtD
Meropenem—Paraesthesia—Bleomycin—melanoma	0.00232	0.00232	CcSEcCtD
Meropenem—Hypertension—Temozolomide—melanoma	0.0023	0.0023	CcSEcCtD
Meropenem—Dyspnoea—Bleomycin—melanoma	0.0023	0.0023	CcSEcCtD
Meropenem—Anorexia—Dactinomycin—melanoma	0.0023	0.0023	CcSEcCtD
Meropenem—Pneumonia—Docetaxel—melanoma	0.00228	0.00228	CcSEcCtD
Meropenem—Confusional state—Carmustine—melanoma	0.00227	0.00227	CcSEcCtD
Meropenem—Infestation NOS—Docetaxel—melanoma	0.00227	0.00227	CcSEcCtD
Meropenem—Infestation—Docetaxel—melanoma	0.00227	0.00227	CcSEcCtD
Meropenem—Anxiety—Temozolomide—melanoma	0.00226	0.00226	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00226	0.00226	CcSEcCtD
Meropenem—Oedema—Carmustine—melanoma	0.00225	0.00225	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00225	0.00225	CcSEcCtD
Meropenem—Decreased appetite—Bleomycin—melanoma	0.00224	0.00224	CcSEcCtD
Meropenem—Infection—Carmustine—melanoma	0.00224	0.00224	CcSEcCtD
Meropenem—Acute coronary syndrome—Docetaxel—melanoma	0.00224	0.00224	CcSEcCtD
Meropenem—Renal failure—Docetaxel—melanoma	0.00223	0.00223	CcSEcCtD
Meropenem—Myocardial infarction—Docetaxel—melanoma	0.00223	0.00223	CcSEcCtD
Meropenem—Neuropathy peripheral—Docetaxel—melanoma	0.00223	0.00223	CcSEcCtD
Meropenem—Jaundice—Docetaxel—melanoma	0.00221	0.00221	CcSEcCtD
Meropenem—Pain—Bleomycin—melanoma	0.00221	0.00221	CcSEcCtD
Meropenem—Thrombocytopenia—Carmustine—melanoma	0.00221	0.00221	CcSEcCtD
Meropenem—Tachycardia—Carmustine—melanoma	0.0022	0.0022	CcSEcCtD
Meropenem—Confusional state—Temozolomide—melanoma	0.0022	0.0022	CcSEcCtD
Meropenem—Anaphylactic shock—Temozolomide—melanoma	0.00218	0.00218	CcSEcCtD
Meropenem—Oedema—Temozolomide—melanoma	0.00218	0.00218	CcSEcCtD
Meropenem—Infection—Temozolomide—melanoma	0.00216	0.00216	CcSEcCtD
Meropenem—Anorexia—Carmustine—melanoma	0.00215	0.00215	CcSEcCtD
Meropenem—Hepatobiliary disease—Docetaxel—melanoma	0.00215	0.00215	CcSEcCtD
Meropenem—Epistaxis—Docetaxel—melanoma	0.00214	0.00214	CcSEcCtD
Meropenem—Nervous system disorder—Temozolomide—melanoma	0.00214	0.00214	CcSEcCtD
Meropenem—Thrombocytopenia—Temozolomide—melanoma	0.00213	0.00213	CcSEcCtD
Meropenem—Feeling abnormal—Bleomycin—melanoma	0.00213	0.00213	CcSEcCtD
Meropenem—Agranulocytosis—Docetaxel—melanoma	0.00212	0.00212	CcSEcCtD
Meropenem—Skin disorder—Temozolomide—melanoma	0.00212	0.00212	CcSEcCtD
Meropenem—Hypotension—Carmustine—melanoma	0.00211	0.00211	CcSEcCtD
Meropenem—Hyperhidrosis—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Meropenem—Decreased appetite—Dactinomycin—melanoma	0.00209	0.00209	CcSEcCtD
Meropenem—Anorexia—Temozolomide—melanoma	0.00208	0.00208	CcSEcCtD
Meropenem—Pain—Dactinomycin—melanoma	0.00206	0.00206	CcSEcCtD
Meropenem—Urticaria—Bleomycin—melanoma	0.00205	0.00205	CcSEcCtD
Meropenem—Haemoglobin—Docetaxel—melanoma	0.00205	0.00205	CcSEcCtD
Meropenem—Body temperature increased—Bleomycin—melanoma	0.00204	0.00204	CcSEcCtD
Meropenem—Hepatitis—Docetaxel—melanoma	0.00204	0.00204	CcSEcCtD
Meropenem—Haemorrhage—Docetaxel—melanoma	0.00204	0.00204	CcSEcCtD
Meropenem—Insomnia—Carmustine—melanoma	0.00204	0.00204	CcSEcCtD
Meropenem—Paraesthesia—Carmustine—melanoma	0.00202	0.00202	CcSEcCtD
Meropenem—Pharyngitis—Docetaxel—melanoma	0.00202	0.00202	CcSEcCtD
Meropenem—Dyspnoea—Carmustine—melanoma	0.00201	0.00201	CcSEcCtD
Meropenem—Oedema peripheral—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Meropenem—Somnolence—Carmustine—melanoma	0.002	0.002	CcSEcCtD
Meropenem—Feeling abnormal—Dactinomycin—melanoma	0.00198	0.00198	CcSEcCtD
Meropenem—Insomnia—Temozolomide—melanoma	0.00197	0.00197	CcSEcCtD
Meropenem—Gastrointestinal pain—Dactinomycin—melanoma	0.00197	0.00197	CcSEcCtD
Meropenem—Decreased appetite—Carmustine—melanoma	0.00196	0.00196	CcSEcCtD
Meropenem—Paraesthesia—Temozolomide—melanoma	0.00196	0.00196	CcSEcCtD
Meropenem—Gastrointestinal disorder—Carmustine—melanoma	0.00195	0.00195	CcSEcCtD
Meropenem—Dyspnoea—Temozolomide—melanoma	0.00194	0.00194	CcSEcCtD
Meropenem—Somnolence—Temozolomide—melanoma	0.00194	0.00194	CcSEcCtD
Meropenem—Erythema multiforme—Docetaxel—melanoma	0.00193	0.00193	CcSEcCtD
Meropenem—Constipation—Carmustine—melanoma	0.00193	0.00193	CcSEcCtD
Meropenem—Pain—Carmustine—melanoma	0.00193	0.00193	CcSEcCtD
Meropenem—Dyspepsia—Temozolomide—melanoma	0.00192	0.00192	CcSEcCtD
Meropenem—Abdominal pain—Dactinomycin—melanoma	0.0019	0.0019	CcSEcCtD
Meropenem—Body temperature increased—Dactinomycin—melanoma	0.0019	0.0019	CcSEcCtD
Meropenem—Hypersensitivity—Bleomycin—melanoma	0.0019	0.0019	CcSEcCtD
Meropenem—Decreased appetite—Temozolomide—melanoma	0.00189	0.00189	CcSEcCtD
Meropenem—Gastrointestinal disorder—Temozolomide—melanoma	0.00188	0.00188	CcSEcCtD
Meropenem—Pain—Temozolomide—melanoma	0.00186	0.00186	CcSEcCtD
Meropenem—Constipation—Temozolomide—melanoma	0.00186	0.00186	CcSEcCtD
Meropenem—Feeling abnormal—Carmustine—melanoma	0.00186	0.00186	CcSEcCtD
Meropenem—Asthenia—Bleomycin—melanoma	0.00185	0.00185	CcSEcCtD
Meropenem—Gastrointestinal pain—Carmustine—melanoma	0.00184	0.00184	CcSEcCtD
Meropenem—Immune system disorder—Docetaxel—melanoma	0.00184	0.00184	CcSEcCtD
Meropenem—Chills—Docetaxel—melanoma	0.00183	0.00183	CcSEcCtD
Meropenem—Pruritus—Bleomycin—melanoma	0.00183	0.00183	CcSEcCtD
Meropenem—Feeling abnormal—Temozolomide—melanoma	0.00179	0.00179	CcSEcCtD
Meropenem—Abdominal pain—Carmustine—melanoma	0.00178	0.00178	CcSEcCtD
Meropenem—Body temperature increased—Carmustine—melanoma	0.00178	0.00178	CcSEcCtD
Meropenem—Gastrointestinal pain—Temozolomide—melanoma	0.00178	0.00178	CcSEcCtD
Meropenem—Erythema—Docetaxel—melanoma	0.00177	0.00177	CcSEcCtD
Meropenem—Hypersensitivity—Dactinomycin—melanoma	0.00177	0.00177	CcSEcCtD
Meropenem—Dysgeusia—Docetaxel—melanoma	0.00174	0.00174	CcSEcCtD
Meropenem—Urticaria—Temozolomide—melanoma	0.00173	0.00173	CcSEcCtD
Meropenem—Asthenia—Dactinomycin—melanoma	0.00173	0.00173	CcSEcCtD
Meropenem—Body temperature increased—Temozolomide—melanoma	0.00172	0.00172	CcSEcCtD
Meropenem—Abdominal pain—Temozolomide—melanoma	0.00172	0.00172	CcSEcCtD
Meropenem—Back pain—Docetaxel—melanoma	0.00172	0.00172	CcSEcCtD
Meropenem—Hypersensitivity—Carmustine—melanoma	0.00166	0.00166	CcSEcCtD
Meropenem—Diarrhoea—Dactinomycin—melanoma	0.00165	0.00165	CcSEcCtD
Meropenem—Vomiting—Bleomycin—melanoma	0.00164	0.00164	CcSEcCtD
Meropenem—Anaemia—Docetaxel—melanoma	0.00164	0.00164	CcSEcCtD
Meropenem—Rash—Bleomycin—melanoma	0.00163	0.00163	CcSEcCtD
Meropenem—Dermatitis—Bleomycin—melanoma	0.00163	0.00163	CcSEcCtD
Meropenem—Asthenia—Carmustine—melanoma	0.00162	0.00162	CcSEcCtD
Meropenem—Hypersensitivity—Temozolomide—melanoma	0.0016	0.0016	CcSEcCtD
Meropenem—Syncope—Docetaxel—melanoma	0.00159	0.00159	CcSEcCtD
Meropenem—Leukopenia—Docetaxel—melanoma	0.00159	0.00159	CcSEcCtD
Meropenem—Asthenia—Temozolomide—melanoma	0.00156	0.00156	CcSEcCtD
Meropenem—Loss of consciousness—Docetaxel—melanoma	0.00156	0.00156	CcSEcCtD
Meropenem—Cough—Docetaxel—melanoma	0.00155	0.00155	CcSEcCtD
Meropenem—Diarrhoea—Carmustine—melanoma	0.00154	0.00154	CcSEcCtD
Meropenem—Pruritus—Temozolomide—melanoma	0.00154	0.00154	CcSEcCtD
Meropenem—Nausea—Bleomycin—melanoma	0.00153	0.00153	CcSEcCtD
Meropenem—Hypertension—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—melanoma	0.00153	0.00153	CcSEcCtD
Meropenem—Rash—Dactinomycin—melanoma	0.00152	0.00152	CcSEcCtD
Meropenem—Chest pain—Docetaxel—melanoma	0.00151	0.00151	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.0015	0.0015	CcSEcCtD
Meropenem—Dizziness—Carmustine—melanoma	0.00149	0.00149	CcSEcCtD
Meropenem—Diarrhoea—Temozolomide—melanoma	0.00149	0.00149	CcSEcCtD
Meropenem—Confusional state—Docetaxel—melanoma	0.00146	0.00146	CcSEcCtD
Meropenem—Anaphylactic shock—Docetaxel—melanoma	0.00145	0.00145	CcSEcCtD
Meropenem—Oedema—Docetaxel—melanoma	0.00145	0.00145	CcSEcCtD
Meropenem—Dizziness—Temozolomide—melanoma	0.00144	0.00144	CcSEcCtD
Meropenem—Infection—Docetaxel—melanoma	0.00144	0.00144	CcSEcCtD
Meropenem—Vomiting—Carmustine—melanoma	0.00143	0.00143	CcSEcCtD
Meropenem—Nausea—Dactinomycin—melanoma	0.00143	0.00143	CcSEcCtD
Meropenem—Shock—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Meropenem—Rash—Carmustine—melanoma	0.00142	0.00142	CcSEcCtD
Meropenem—Nervous system disorder—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Meropenem—Dermatitis—Carmustine—melanoma	0.00142	0.00142	CcSEcCtD
Meropenem—Thrombocytopenia—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Meropenem—Tachycardia—Docetaxel—melanoma	0.00141	0.00141	CcSEcCtD
Meropenem—Headache—Carmustine—melanoma	0.00141	0.00141	CcSEcCtD
Meropenem—Skin disorder—Docetaxel—melanoma	0.00141	0.00141	CcSEcCtD
Meropenem—Vomiting—Temozolomide—melanoma	0.00138	0.00138	CcSEcCtD
Meropenem—Anorexia—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Meropenem—Rash—Temozolomide—melanoma	0.00137	0.00137	CcSEcCtD
Meropenem—Dermatitis—Temozolomide—melanoma	0.00137	0.00137	CcSEcCtD
Meropenem—Headache—Temozolomide—melanoma	0.00136	0.00136	CcSEcCtD
Meropenem—Hypotension—Docetaxel—melanoma	0.00135	0.00135	CcSEcCtD
Meropenem—Nausea—Carmustine—melanoma	0.00134	0.00134	CcSEcCtD
Meropenem—Insomnia—Docetaxel—melanoma	0.00131	0.00131	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—melanoma	0.0013	0.0013	CcSEcCtD
Meropenem—Nausea—Temozolomide—melanoma	0.00129	0.00129	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—melanoma	0.00129	0.00129	CcSEcCtD
Meropenem—Somnolence—Docetaxel—melanoma	0.00129	0.00129	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—melanoma	0.00127	0.00127	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—melanoma	0.00126	0.00126	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—melanoma	0.00125	0.00125	CcSEcCtD
Meropenem—Pain—Docetaxel—melanoma	0.00124	0.00124	CcSEcCtD
Meropenem—Constipation—Docetaxel—melanoma	0.00124	0.00124	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—melanoma	0.00119	0.00119	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—melanoma	0.00118	0.00118	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—melanoma	0.00114	0.00114	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—melanoma	0.00114	0.00114	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—melanoma	0.00107	0.00107	CcSEcCtD
Meropenem—Asthenia—Docetaxel—melanoma	0.00104	0.00104	CcSEcCtD
Meropenem—Pruritus—Docetaxel—melanoma	0.00102	0.00102	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—melanoma	0.000991	0.000991	CcSEcCtD
Meropenem—Dizziness—Docetaxel—melanoma	0.000958	0.000958	CcSEcCtD
Meropenem—Vomiting—Docetaxel—melanoma	0.000921	0.000921	CcSEcCtD
Meropenem—Rash—Docetaxel—melanoma	0.000913	0.000913	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—melanoma	0.000912	0.000912	CcSEcCtD
Meropenem—Headache—Docetaxel—melanoma	0.000907	0.000907	CcSEcCtD
Meropenem—Nausea—Docetaxel—melanoma	0.00086	0.00086	CcSEcCtD
